Skip to main content

Table 4 Costs related to advanced NSCLC stratified by patients and caregivers

From: Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

Mean annual costs per patient/caregiver Patients
(N = 1030)
Caregivers
(N = 427)
Wage losses n = 1000
€2077
n = 360
€436
Direct out-of-pocket expenses (unadjusted) n = 544
€3774
n = 213
€1756
Direct out-of-pocket expenses (adjusteda) n = 539
€823
n = 203
€1019
Productivity losses n = 966
€1484
n = 387
€2839
Total direct and indirect out-of-pocket costs (unadjusted) n = 522
€5691
n = 204
€4125
Financial support received from government n = 989
€2110
n = 386
€721
Total direct and indirect out-of-pocket costs (adjusteda) n = 518
€2644
n = 194
€3477
  1. NSCLC non-small cell lung cancer
  2. aAdjusted for financial support provided by the respective governments